
### [MONDO:0003914](http://purl.obolibrary.org/obo/MONDO_0003914)
**Label:** purine-pyrimidine metabolic disorder

**Subclasses:** [MONDO:0018106](http://purl.obolibrary.org/obo/MONDO_0018106) (hereditary xanthinuria), [MONDO:0010209](http://purl.obolibrary.org/obo/MONDO_0010209) (xanthinuria type i), [MONDO:0010298](http://purl.obolibrary.org/obo/MONDO_0010298) (Lesch-Nyhan syndrome), [MONDO:0010130](http://purl.obolibrary.org/obo/MONDO_0010130) (dihydropyrimidine dehydrogenase deficiency), [MONDO:0010642](http://purl.obolibrary.org/obo/MONDO_0010642) (Lesch-Nyhan phenotype with normal Hgprt), [MONDO:0011346](http://purl.obolibrary.org/obo/MONDO_0011346) (xanthinuria type II), 

**Corr. equiv. classes:** [Orphanet:93602](http://www.orpha.net/ORDO/Orphanet_93602), [Orphanet:1675](http://www.orpha.net/ORDO/Orphanet_1675), [Orphanet:93601](http://www.orpha.net/ORDO/Orphanet_93601), [OMIM:308950](http://purl.obolibrary.org/obo/OMIM_308950), [OMIM:274270](http://purl.obolibrary.org/obo/OMIM_274270), [OMIM:300322](http://purl.obolibrary.org/obo/OMIM_300322), [Orphanet:510](http://www.orpha.net/ORDO/Orphanet_510), [OMIM:278300](http://purl.obolibrary.org/obo/OMIM_278300), [Orphanet:3467](http://www.orpha.net/ORDO/Orphanet_3467), [OMIM:603592](http://purl.obolibrary.org/obo/OMIM_603592), 

**Class expressions from DL-Learner:**

- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) 65.00%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0002149](http://purl.obolibrary.org/obo/HP_0002149) (Hyperuricemia) 65.00%
- [HP:0001257](http://purl.obolibrary.org/obo/HP_0001257) (Spasticity) and [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) 65.00%
- [HP:0001257](http://purl.obolibrary.org/obo/HP_0001257) (Spasticity) and [HP:0002149](http://purl.obolibrary.org/obo/HP_0002149) (Hyperuricemia) 65.00%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 65.00%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 65.00%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0004364](http://purl.obolibrary.org/obo/HP_0004364) (Abnormality of nitrogen compound homeostasis) and [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) 65.00%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0002157](http://purl.obolibrary.org/obo/HP_0002157) (Azotemia) and [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) 65.00%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0002149](http://purl.obolibrary.org/obo/HP_0002149) (Hyperuricemia) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 65.00%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0002149](http://purl.obolibrary.org/obo/HP_0002149) (Hyperuricemia) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 65.00%
- [HP:0001257](http://purl.obolibrary.org/obo/HP_0001257) (Spasticity) and [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 65.00%
- [HP:0001257](http://purl.obolibrary.org/obo/HP_0001257) (Spasticity) and [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 65.00%
- [HP:0001257](http://purl.obolibrary.org/obo/HP_0001257) (Spasticity) and [HP:0004364](http://purl.obolibrary.org/obo/HP_0004364) (Abnormality of nitrogen compound homeostasis) and [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) 65.00%
- [HP:0001257](http://purl.obolibrary.org/obo/HP_0001257) (Spasticity) and [HP:0002157](http://purl.obolibrary.org/obo/HP_0002157) (Azotemia) and [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) 65.00%
- [HP:0001257](http://purl.obolibrary.org/obo/HP_0001257) (Spasticity) and [HP:0002149](http://purl.obolibrary.org/obo/HP_0002149) (Hyperuricemia) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 65.00%


